Pulpotomies on Primary Molars
Conditions
Brief summary
The objective of this prospective randomized clinical trial is to assess clinically and radiographically, the effect of NeoPutty as a pulp medicament following coronal pulp amputation in human primary molars with carious pulp exposure in comparison to Formocresol (FC).
Interventions
OTHERNeo-Putty® as dressing agents in pulpotomized primary molars
Following removal of the coronal pulp with a round bur and hemostasis, the pulp stumps in the study group will be covered with Neo-Putty ® according to the manufacturer's instructions. Neo-Putty will be placed in the prepared cavity, and then covered with Vitrebond® and with a reinforced Zinc Oxide-Eugenol (IRM, Bayer-Leverkussen, Germany). In the control group, a cotton pellet moistened with full-strength FC will be placed for 5 minutes on the amputated pulp, after reaching hemostasis. The pulp stumps will be then covered by IRM
Sponsors
Hadassah Medical Organization
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
2 Years to 10 Years
Healthy volunteers
Yes
Inclusion criteria
* primary teeth which requires pulpotomy.
Exclusion criteria
* not healthy patients, * teeth which requires pulpectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of the primary molar pulpotomy | One year |
Countries
Israel
Outcome results
None listed